Pages that link to "Q40663773"
Jump to navigation
Jump to search
The following pages link to Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid (Q40663773):
Displaying 24 items.
- Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein (Q24813809) (← links)
- A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques (Q27472927) (← links)
- Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus (Q27487131) (← links)
- Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. (Q34300986) (← links)
- Adenoviruses as vaccine vectors (Q34353523) (← links)
- Progress on new vaccine strategies against chronic viral infections (Q35864857) (← links)
- Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease (Q36026890) (← links)
- Adenovirus as vehicle for anticancer genetic immunotherapy (Q36288930) (← links)
- Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes (Q36328978) (← links)
- Baculovirus vectors elicit antigen-specific immune responses in mice (Q36684637) (← links)
- Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments (Q36900143) (← links)
- Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. (Q37349027) (← links)
- Adenovirus-vectored vaccines (Q37689799) (← links)
- DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. (Q37866631) (← links)
- An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee Model (Q39813695) (← links)
- Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice (Q39843759) (← links)
- Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice (Q41087956) (← links)
- Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen (Q41451838) (← links)
- T-bet is required for protection against vaccinia virus infection (Q42094910) (← links)
- Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4 T-cells. (Q42829978) (← links)
- Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer. (Q43903695) (← links)
- Immune response induced by a different combined immunization of HBsAg vaccine (Q44784875) (← links)
- Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice (Q64377682) (← links)
- The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection (Q83817670) (← links)